Pfizer

Update news Pfizer

Vietnam to have additional 6 million doses of Pfizer, AstraZeneca Covid-19 vaccines

Vietnam expects to have 3 million doses of AstraZeneca vaccine and 3 million doses of Pfizer vaccine from now to September.

Details of 120 million doses of Covid-19 vaccine for Vietnam this year announced

Vietnam has completed negotiations with at least four pharmaceutical companies to buy more than 120 million doses of Covid-19 vaccine this year, the Ministry of Health has announced.

Vietnam to receive 5 million more doses of AstraZeneca and Pfizer vaccines

In the next two months, Vietnam will have at least 5 million more doses of AstraZeneca and Pfizer vaccines, according to Deputy Health Minister Do Xuan Tuyen.

Vietnam to get 31 million Pfizer vaccine doses in Q3, Q4

Vietnam is expected to get 31 million COVID-19 vaccine doses developed by US-based firm Pfizer in the third and fourth quarters of 2021, said the Ministry of Health (MoH).

Vietnam likely to ink contract of Pfizer-BioNTech vaccine today

Vietnam’s Prime Minister said purchasing vaccine is an urgent task and must be done at the earliest.

Covid-19 vaccine and the gap between countries

The US announcement to support the waiver of IP protection on Covid-19 vaccine has not been the good news that was previously expected.

Drug price hikes in US threaten the same in Vietnam?

Pfizer, Sanofi, and GlaxoSmithKline are reported to plan increasing drug prices in the US in 2020, triggering public concerns over a similar hike in Vietnam.

Pfizer, Astellas prostate cancer drug promising in late-stage trial

 Pfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages.

UK agency says Pfizer breast cancer drug too expensive

 Pfizer's breast cancer drug Ibrance, or palbociclib, is too expensive to justify its use on Britain's state-run health service, the country's healthcare cost-effectiveness watchdog said on Friday.